VERSANT VENTURE CAPITAL I LP 3
Accession 0001181431-11-008843
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 9:42 PM ET
Size
43.2 KB
Accession
0001181431-11-008843
Insider Transaction Report
- (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (5,185 underlying) - (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (2,092 underlying) - 7,596(indirect: See Footnotes)
Series E1 Preferred
- (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (6,401 underlying) - (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (3,715 underlying) - (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (13,442 underlying) - (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (5,760 underlying) - 346(indirect: See Footnotes)
Series E1 Preferred
- (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (1,769 underlying) - (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (2,065 underlying) - (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (7,297 underlying) - (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (29,190 underlying) - 148(indirect: See Footnotes)
Series E1 Preferred
- (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (1,417 underlying) - 164(indirect: See Footnotes)
Series E1 Preferred
- (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (10,425 underlying) - (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (26,181 underlying) - (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (103,546 underlying) - (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (474,354 underlying) - (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (81,396 underlying) - (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (479 underlying) - (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (294,457 underlying) - (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (544 underlying) - (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (1,592 underlying)
- (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (26,181 underlying) - (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (103,546 underlying) - (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (10,425 underlying) - 164(indirect: See Footnotes)
Series E1 Preferred
- 346(indirect: See Footnotes)
Series E1 Preferred
- 148(indirect: See Footnotes)
Series E1 Preferred
- (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (479 underlying) - (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (7,297 underlying) - (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (1,417 underlying) - (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (5,185 underlying) - (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (2,092 underlying) - (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (294,457 underlying) - (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (2,065 underlying) - (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (29,190 underlying) - (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (544 underlying) - (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (5,760 underlying) - 7,596(indirect: See Footnotes)
Series E1 Preferred
- (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (1,769 underlying) - (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (13,442 underlying) - (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (3,715 underlying) - (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (1,592 underlying) - (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (474,354 underlying) - (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (81,396 underlying) - (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (6,401 underlying)
- 346(indirect: See Footnotes)
Series E1 Preferred
- 148(indirect: See Footnotes)
Series E1 Preferred
- (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (544 underlying) - (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (26,181 underlying) - (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (294,457 underlying) - (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (5,760 underlying) - (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (2,065 underlying) - 164(indirect: See Footnotes)
Series E1 Preferred
- (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (6,401 underlying) - (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (1,769 underlying) - (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (5,185 underlying) - (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (7,297 underlying) - (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (2,092 underlying) - (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (10,425 underlying) - (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (1,592 underlying) - (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (474,354 underlying) - 7,596(indirect: See Footnotes)
Series E1 Preferred
- (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (1,417 underlying) - (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (13,442 underlying) - (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (3,715 underlying) - (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (103,546 underlying) - (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (81,396 underlying) - (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (479 underlying) - (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (29,190 underlying)
- 7,596(indirect: See Footnotes)
Series E1 Preferred
- (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (2,065 underlying) - (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (6,401 underlying) - (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (5,185 underlying) - (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (103,546 underlying) - 164(indirect: See Footnotes)
Series E1 Preferred
- 346(indirect: See Footnotes)
Series E1 Preferred
- (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (1,417 underlying) - (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (474,354 underlying) - (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (294,457 underlying) - 148(indirect: See Footnotes)
Series E1 Preferred
- (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (479 underlying) - (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (1,769 underlying) - (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (29,190 underlying) - (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (3,715 underlying) - (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (81,396 underlying) - (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (7,297 underlying) - (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (13,442 underlying) - (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (544 underlying) - (indirect: See footnotes)
Series E Preferred Stock
Exercise: $0.00→ Common Stock (2,092 underlying) - (indirect: See footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (10,425 underlying) - (indirect: See footnotes)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (5,760 underlying) - (indirect: See footnotes)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (1,592 underlying) - (indirect: See footnotes)
Series E Preferred Warrant (Right to Buy)
Exercise: $24.22→ Common Stock (26,181 underlying)
Footnotes (10)
- [F1]Reflects a 1-for-1.73 reverse stock split of the Issuer's outstanding shares effected February 3, 2011.
- [F10]Each share has no expiration date.
- [F2]Versant Affiliates Fund 1-A, L.P., is the record holder of the securities.
- [F3]Voting and investment power over the shares directly held by Versant Venture Capital I, L.P., Versant Affiliates Fund I-A, L.P., Versant Affiliates Fund I-B, L.P., and Versant Side Fund I, L.P. is held by Versant Ventures I, LLC, their sole General Partner. Samuel D. Colella, the reporting person is a Managing Member of Versant Ventures I, LLC but he disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The individual Managing Members of Versant Ventures I, LLC are Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, and Rebecca B. Robertson, all of whom share voting and dispositive control. Each respective individual General Partner disclaims beneficial ownership of these shares, except to the extent of their pecuniary interest therein.
- [F4]Versant Affiliates Fund 1-B, L.P., is the record holder of the securities.
- [F5]Versant Side Fund 1, L.P., is the record holder of the securities.
- [F6]Versant Venture Capital I, L.P., is the record holder of the securities.
- [F7]Reflects the automatic conversion of each share of Series E Preferred Stock into 1.3 shares of Common Stock to occur upon the closing of the Issuer's initial public offering.
- [F8]Expires immediately prior to the closing of the Issuer's initial public offering.
- [F9]Reflects the automatic conversion of each share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E1 Preferred Stock into one share of Common Stock to occur upon the closing of the Issuer's initial public offering. Each share has no expiration date.
Issuer
FLUIDIGM CORP
CIK 0001162194
Related Parties
1- filerCIK 0001268786
Filing Metadata
- Form type
- 3
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 9:42 PM ET
- Size
- 43.2 KB